动脉样硬化从新生儿到成年人-流行病学,病理方面和危险因素
Alina Costina Luca1, Simona Georgiana David2, Alexandru Gabriel David2
1Pediatrics Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Life (Basel, Switzerland)
|October 28, 2023
概括
动脉样硬化是一种慢性炎症性疾病,始于童年,是心血管疾病死亡的主要原因. 早期识别儿童的脂质不良和肥胖等危险因素对于预防至关重要.
科学领域:
- 心血管医学 心血管医学
- 儿科病理学 儿科病理学
- 免疫学 免疫学 免疫学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,大多数病例的基础是动脉样硬化.
- 动脉样硬化是一种慢性,免疫-炎症过程,从儿童时期开始,脂肪条纹并进展到复杂的斑块.
- 导致冠状动脉血栓形成的斑块破裂是心血管疾病死亡的常见原因,全球患病率不断增加.
研究的目的:
- 审查当前对动脉样硬化在儿童时期的起源和进展的理解.
- 在儿童群体中确定动脉样硬化心血管疾病的已知风险因素.
主要方法:
- 本综述综合了来自流行病学研究和现有文献的信息.
- 专注于儿童早期的病理变化和已识别的风险因素.
主要成果:
- 动脉样硬化始于童年,其特点是动脉中脂肪和炎症细胞的积累.
- 确定的主要危险因素包括脂质不良,高血压,糖尿病,肥胖和吸烟.
- 这些因素有助于为动脉样硬化的早期病原性基础.
结论:
- 动脉样硬化是一种早期发病的疾病,具有显著的长期心血管影响.
- 了解儿童风险因素对于预防成人心血管疾病至关重要.
- 对儿科患者群体需要进一步的研究和早期干预策略.
相关概念视频
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Atherosclerosis IV: Nursing Management
17
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
17
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Coronary Artery Disease I: Introduction
17
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12


